We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
The cytotoxicagent temozolomide has also demonstrated activity in patients with advanced sarcoma.
2
Pemetrexed is the first third-generation cytotoxicagent tolerable at full dose in this setting.
3
Current palliative therapeutic approaches mostly focused on evaluating chemotherapy regimens in which gemcitabine is combined with a second cytotoxicagent.
4
Clinicians should be aware of the potential acute fatal side effect of this otherwise well tolerated and widely used cytotoxicagent.
5
Pancreatic cancer has proven to be chemo-resistant, with gemcitabine being the only cytotoxicagent approved for advanced pancreatic cancer since 1996.
6
The cumulative experience of single-agent paclitaxel in advanced, metastatic NSCLC suggests that it is a highly active cytotoxicagent in this setting.
7
The proposed method has been validated and, subsequently, implemented in a phase I clinical trial for pharmacokinetic evaluation of the new cytotoxicagent.
8
To the authors' knowledge, there have been no published reports of this phenomenon after the administration of the widely applied cytotoxicagent raltitrexed.
9
We believe that this 3 step induction process is common for any cytotoxicagent that induces chromosomal aberrations after DNA replication has been inhibited.
10
Then, the changes in the permeability of the cell membrane to a cytotoxicagent (bleomycin) were assessed by a cloning efficacy test.
11
A number of cytotoxicagents, alone and in combination, have shown activity.
12
Second and 3rd trimester exposure to cytotoxicagents may predispose to placental underdevelopment.
13
Studies incorporating additional cytotoxicagents demonstrate increased morbidity with little benefit.
14
Background: The search for natural products as potential cytotoxicagents has yielded promising candidates.
15
While chemotherapies with cytotoxicagents have demonstrated initial treatment response, most tumors recur quickly.
16
Antitumor effects were equal or superior to that of several clinically approved cytotoxicagents.